Susan M. Burks Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
General Health Scientist
faculty
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Susan M. Burks' research investigates mechanisms of neurotoxicity and neurodegenerative diseases, with a focus on dopaminergic systems and the potential impact of viral infections on the central nervous system. Her work has explored the role of autophagy and protein aggregation in dopaminergic degeneration, using primary human neuronal models. Additionally, she has examined the potential for SARS-CoV-2 to infect the central nervous system, investigating pathways such as the olfactory bulb and the blood-brain barrier. Her research also includes the evaluation of circulating biomarkers for neurotoxicity in rodent models. Burks has collaborated with researchers at the National Center for Toxicological Research, including John Talpos and Manuel Alejandro Ramirez-Lee, on several publications. Her scholarship metrics include an h-index of 6 across 10 publications with over 300 citations.
Metrics
- h-index: 7
- Publications: 10
- Citations: 321
Selected Publications
-
Autophagy and protein aggregation as a mechanism of dopaminergic degeneration in a primary human dopaminergic neuronal model (2022)
-
Circulating biomarkers of neurotoxicity: Proteomics approach reveals fluidic endpoints of central nervous system toxicity in a rodent model of neurotoxicity (2021)
-
Genotoxicity evaluation using primary hepatocytes isolated from rhesus macaque (Macaca mulatta) (2021)
-
Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier? (2021)
Collaboration Network
Top Collaborators
- Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier?
- Autophagy and protein aggregation as a mechanism of dopaminergic degeneration in a primary human dopaminergic neuronal model
- Circulating biomarkers of neurotoxicity: Proteomics approach reveals fluidic endpoints of central nervous system toxicity in a rodent model of neurotoxicity
- Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier?
- Genotoxicity evaluation using primary hepatocytes isolated from rhesus macaque (Macaca mulatta)
- Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier?
- Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier?
- Genotoxicity evaluation using primary hepatocytes isolated from rhesus macaque (Macaca mulatta)
- Genotoxicity evaluation using primary hepatocytes isolated from rhesus macaque (Macaca mulatta)
- Genotoxicity evaluation using primary hepatocytes isolated from rhesus macaque (Macaca mulatta)
- Genotoxicity evaluation using primary hepatocytes isolated from rhesus macaque (Macaca mulatta)
- Genotoxicity evaluation using primary hepatocytes isolated from rhesus macaque (Macaca mulatta)
- Genotoxicity evaluation using primary hepatocytes isolated from rhesus macaque (Macaca mulatta)
- Genotoxicity evaluation using primary hepatocytes isolated from rhesus macaque (Macaca mulatta)
- Circulating biomarkers of neurotoxicity: Proteomics approach reveals fluidic endpoints of central nervous system toxicity in a rodent model of neurotoxicity
- Circulating biomarkers of neurotoxicity: Proteomics approach reveals fluidic endpoints of central nervous system toxicity in a rodent model of neurotoxicity
- Circulating biomarkers of neurotoxicity: Proteomics approach reveals fluidic endpoints of central nervous system toxicity in a rodent model of neurotoxicity
- Circulating biomarkers of neurotoxicity: Proteomics approach reveals fluidic endpoints of central nervous system toxicity in a rodent model of neurotoxicity
Similar Researchers
Based on overlapping research topics